Advertisement

Psychopharmacology

, Volume 231, Issue 7, pp 1429–1431 | Cite as

New glutamatergic target for alcohol and substance use disorder medications

  • Csaba VadaszEmail author
  • Mariko Saito
Commentary
  • 331 Downloads

Traditionally, theories of dopamine reward (Wise 1996; Wise and Bozarth 1987) dominated the field of alcohol and substance use disorder. The brain's most abundant neurotransmitter, glutamate, only later emerged as an equally important player (Cornish and Kalivas 2000; Kalivas et al. 2003). Over the past couple of years, several reports in psychopharmacology investigated the role of glutamatergic neurotransmission in the development of alcohol and substance use disorders (Holmes et al. 2013; Newman et al. 2012; von der Goltz et al. 2009).

The latest review in a special issue of psychopharmacology focused on glutamatergic targets for new alcohol medications (Holmes et al. 2013). While the authors provide an informative overview of several components of the glutamate system with established roles in alcohol-related behaviors [the N-methyl-d-aspartate (NMDA) receptor and specific NMDA receptor subunits, the glycine B site on the NMDA receptors, l-alpha-amino-3-hydroxy-5-methyl-isoxazole-4-...

References

  1. Backstrom P, Bachteler D, Koch S, Hyytia P, Spanagel R (2004) mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology 29:921–928PubMedCrossRefGoogle Scholar
  2. Bahi A (2011) The pre-synaptic metabotropic glutamate receptor 7 "mGluR7" is a critical modulator of ethanol sensitivity in mice. Neuroscience 199:13–23PubMedCrossRefGoogle Scholar
  3. Bahi A (2012) The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 prevents reinstatement of extinguished ethanol-induced conditioned place preference in mice. Pharmacol Biochem Behav 101:193–200PubMedCrossRefGoogle Scholar
  4. Bahi A (2013) Viral-mediated knockdown of mGluR7 in the nucleus accumbens mediates excessive alcohol drinking and increased ethanol-elicited conditioned place preference in rats. Neuropsychopharmacology 38:2109–2119PubMedCrossRefGoogle Scholar
  5. Bahi A, Fizia K, Dietz M, Gasparini F, Flor PJ (2012) Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in rats. Addict Biol 17:235–247PubMedCrossRefGoogle Scholar
  6. Cornish JL, Kalivas PW (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20:RC89PubMedGoogle Scholar
  7. Cowen MS, Djouma E, Lawrence AJ (2005) The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems. J Pharmacol Exp Ther 315:590–600PubMedCrossRefGoogle Scholar
  8. Fendt M, Schmid S, Thakker DR, Jacobson LH, Yamamoto R, Mitsukawa K, Maier R, Natt F, Husken D, Kelly PH, McAllister KH, Hoyer D, van der Putten H, Cryan JF, Flor PJ (2008) mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity. Mol Psychiatry 13:970–979PubMedCrossRefGoogle Scholar
  9. Gyetvai B, Simonyi A, Oros M, Saito M, Smiley J, Vadasz C (2011) mGluR7 genetics and alcohol: intersection yields clues for addiction. Neurochem Res 36:1087–1100PubMedCrossRefGoogle Scholar
  10. Hodge CW, Miles MF, Sharko AC, Stevenson RA, Hillmann JR, Lepoutre V, Besheer J, Schroeder JP (2006) The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. Psychopharmacol (Berl) 183:429–438CrossRefGoogle Scholar
  11. Holmes A, Spanagel R, Krystal JH (2013) Glutamatergic targets for new alcohol medications. Psychopharmacol (Berl) 229:539–554CrossRefGoogle Scholar
  12. Joslyn G, Ravindranathan A, Brush G, Schuckit M, White RL (2010) Human variation in alcohol response is influenced by variation in neuronal signaling genes. Alcohol Clin Exp Res 34:800–812PubMedCrossRefGoogle Scholar
  13. Kalivas PW, McFarland K, Bowers S, Szumlinski K, Xi ZX, Baker D (2003) Glutamate transmission and addiction to cocaine. Ann N Y Acad Sci 1003:169–175PubMedCrossRefGoogle Scholar
  14. Li X, Li J, Peng XQ, Spiller K, Gardner EL, Xi ZX (2009) Metabotropic glutamate receptor 7 modulates the rewarding effects of cocaine in rats: involvement of a ventral pallidal GABAergic mechanism. Neuropsychopharmacology 34:1783–1796PubMedCrossRefPubMedCentralGoogle Scholar
  15. Li X, Li J, Gardner EL, Xi ZX (2010) Activation of mGluR7s inhibits cocaine-induced reinstatement of drug-seeking behavior by a nucleus accumbens glutamate-mGluR2/3 mechanism in rats. J Neurochem 114:1368–1380PubMedCrossRefPubMedCentralGoogle Scholar
  16. Li C, Li Y, Xu J, Lv J, Ma Y, Shao T, Gong B, Tan R, Xiao Y, Li X (2011) Disease-driven detection of differential inherited SNP modules from SNP network. Gene 489:119–129PubMedCrossRefGoogle Scholar
  17. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F et al (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224–2260PubMedCrossRefGoogle Scholar
  18. Mitsukawa K, Yamamoto R, Ofner S, Nozulak J, Pescott O, Lukic S, Stoehr N, Mombereau C, Kuhn R, McAllister KH, van der Putten H, Cryan JF, Flor PJ (2005) A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo. Proc Natl Acad Sci U S A 102:18712–18717PubMedCrossRefPubMedCentralGoogle Scholar
  19. Mitsukawa K, Mombereau C, Lotscher E, Uzunov DP, van der Putten H, Flor PJ, Cryan JF (2006) Metabotropic glutamate receptor subtype 7 ablation causes dysregulation of the HPA axis and increases hippocampal BDNF protein levels: implications for stress-related psychiatric disorders. Neuropsychopharmacology 31:1112–1122PubMedGoogle Scholar
  20. Newman EL, Chu A, Bahamon B, Takahashi A, Debold JF, Miczek KA (2012) NMDA receptor antagonism: escalation of aggressive behavior in alcohol-drinking mice. Psychopharmacol (Berl) 224:167–177CrossRefGoogle Scholar
  21. Rhodes JS, Best K, Belknap JK, Finn DA, Crabbe JC (2005) Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiol Behav 84:53–63PubMedCrossRefGoogle Scholar
  22. Salling MC, Faccidomo S, Hodge CW (2008) Nonselective suppression of operant ethanol and sucrose self-administration by the mGluR7 positive allosteric modulator AMN082. Pharmacol Biochem Behav 91:14–20PubMedCrossRefPubMedCentralGoogle Scholar
  23. Schroeder JP, Overstreet DH, Hodge CW (2005) The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacol (Berl) 179:262–270CrossRefGoogle Scholar
  24. Suzuki G, Tsukamoto N, Fushiki H, Kawagishi A, Nakamura M, Kurihara H, Mitsuya M, Ohkubo M, Ohta H (2007) In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists. J Pharmacol Exp Ther 323:147–156PubMedCrossRefGoogle Scholar
  25. Vadasz C, Saito M, Gyetvai BM, Oros M, Szakall I, Kovacs KM, Prasad VV, Toth R (2007) Glutamate receptor metabotropic 7 is cis-regulated in the mouse brain and modulates alcohol drinking. Genomics 90:690–702PubMedCrossRefGoogle Scholar
  26. von der Goltz C, Vengeliene V, Bilbao A, Perreau-Lenz S, Pawlak CR, Kiefer F, Spanagel R (2009) Cue-induced alcohol-seeking behaviour is reduced by disrupting the reconsolidation of alcohol-related memories. Psychopharmacol (Berl) 205:389–397CrossRefGoogle Scholar
  27. Wise RA (1996) Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319–340PubMedCrossRefGoogle Scholar
  28. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492PubMedCrossRefGoogle Scholar
  29. Zhou Z, Karlsson C, Liang T, Xiong W, Kimura M, Tapocik JD, Yuan Q, Barbier E, Feng A, Flanigan M, Augier E, Enoch MA, Hodgkinson CA, Shen PH, Lovinger DM, Edenberg HJ, Heilig M, Goldman D (2013) Loss of metabotropic glutamate receptor 2 escalates alcohol consumption. Proc Natl Acad Sci U S A 110:16963–16968PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Nathan Kline Institute, Neurobehavioral GeneticsNew York University School of Medicine, PsychiatryNew YorkUSA

Personalised recommendations